A psychometric analysis of quality of life tools in lung cancer patients who smoke

Lung Cancer

Volumn 66, Issue 1, 2009, Pages 134-139

  Browning, Kristine K ^a,b   Ferketich, Amy K ^a   Otterson, Gregory A ^b,c   Reynolds, Nancy R ^d   Wewers, Mary Ellen ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Lung cancer; Psychometric analysis; Quality of life; Questionnaire; Smoking; Tobacco use

Indexed keywords

ADULT; AGED; ARTICLE; CONSTRUCT VALIDITY; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY; HUMAN; INTERNAL CONSISTENCY; LUNG CANCER; LUNG CANCER SYMPTOM SCALE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADULT; AGED; AGED, 80 AND OVER; DEMOGRAPHY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SMOKING; TREATMENT OUTCOME;

EID: 68949209949     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.12.018     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 58 2 (2008) 71-96
2. 5-Year relative survival rates by race for lung and bronchus cancer [homepage on the Internet]. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2007. Available from: http://canques.seer.cancer.gov.
3. Ettinger D.S., Bepler G., Bueno R., Chang A., Chang J.Y., Chirieac L.R., et al. Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 4 6 (2006) 548-582
4. Hollen P.J., Gralla R.J., and Rittenberg C.N. Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer. Support Care Cancer 12 November (11) (2004) 767-773
5. SEER cancer statistics review, 1974-2004 [homepage on the Internet]. Bethesda, MD: National Cancer Institute; 2006. Available from: http://seer.cancer.gov.proxy.lib.ohio-state.edu/csr/1975_2004/.
6. Cella D. Impact of ZD1839 on non-small cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale. Semin Oncol 30 1 Suppl. (1) (2003) 39-48
7. Sarna L., Padilla G., Holmes C., Tashkin D., Brecht M.L., and Evaneglista L. Quality of life of long-term survivors of non-small cell lung cancer. J Clin Oncol 20 13 (2002) 2920-2929
8. Donovan K., Sanson-Fisher R.W., and Redman S. Measuring quality of life in cancer patients. J Clin Oncol 7 7 (1989) 959-968
9. Hollen P.J., and Gralla R.J. Comparison of instruments for measuring quality of life in patients with lung cancer. Semin Oncol 23 2 Suppl. (5) (April 1996) 31-40
10. Cella D., Bonomi A., Lloyd S., Tulsky D., Kaplan E., and Bonomi P. Reliability and validity of the functional assessment of cancer therapy-lung (FACT-L) quality of life instrument. Lung Cancer 12 (1995) 199-220
11. Cella D., Tulsky D., Blendowski C., Goodman M., Barnicle M., Stewart I., et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11 3 (1993) 570-579
12. Hollen P.J., Gralla R.J., Kris M.G., and Potanovich L.M. Quality of life assessment in individuals with lung cancer: testing the lung cancer symptom scale (LCSS). Eur J Cancer 29A Suppl. (1) (1993) S51-S58
13. USDHHS. The health consequences of smoking, nicotine addiction: a report of the surgeon general. Rockville, Maryland; 1988.
14. Evangelista L.S., Sarna L., Brecht M.L., Padilla G., and Chen J. Health perceptions and risk behaviors of lung cancer survivors. Heart Lung 32 2 (2003) 131-139
15. Cox L., Sloan J., Patten C., Bonner J., Geyer S., McGinnis W., et al. Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. Psychooncology 11 (2002) 472-478
16. Schnoll R., Zhang B., Rue M., Krook J., Spears W., Marcus A., et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinating by the eastern cooperative oncology group. J Clin Oncol 21 2 (2003) 355-365
17. Schnoll R., Malstom M., James C., Rothman R., Miller S., Ridge J., et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns 46 (2002) 137-145
18. Wilson D., Parsons J., and Wakefield M. The health-related quality-of-life of never smokers, ex-smokers, and light, moderate, and heavy smokers. Prev Med 29 September (3) (1999) 139-144
19. Tillmann M., and Silcock J. A comparison of smokers' and ex-smokers' health-related quality of life. J Public Health Med 19 September (3) (1997) 268-273
20. Garces Y.I., Yang P., Parkinson J., Zhao X., Wampfler J.A., Ebbert J.O., et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 126 December (6) (2004) 1733-1741
21. Hollen P.J., Gralla R.J., Kris M.G., Cox C., Belani C.P., Grunberg S.M., et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the lung cancer symptom scale. Cancer 73 April (8) (1994) 2087-2098
22. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerström K.O. The fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. Br J Addict 86 (1991) 1119-1127
23. Cella D., Herbst R.S., Lynch T.J., Prager D., Belani C.P., Schiller J.H., et al. Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial. J Clin Oncol 23 13 (2005) 2946-2954
24. Nunnally J., and Bernstein I. Psychometric theory (1994), McGraw-Hill, Inc., New York
25. Montgomery D.C., and Peck E.A. Introduction to linear regression analysis (1992), John Wiley & Sons, Inc., New York
26. Hollen P.J., Gralla R.J., Kris M.G., Eberly S.W., and Cox C. Normative data and trends in quality of life from the lung cancer symptom scale (LCSS). Support Care Cancer 7 May (3) (1999) 140-148
27. Hollen P.J., Gralla R.J., Kris M.G., McCoy S., Donaldson G.W., and Moinpour C.M. A comparison of visual analogue and numerical rating scale formats for the lung cancer symptom scale (LCSS): does format affect patient ratings of symptoms and quality of life?. Qual Life Res 14 April (3) (2005) 837-847
28. Wewers M.E., and Lowe N.K. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13 August (4) (1990) 227-236
29. Montazeri A., Gillis C.R., and McEwen J. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest 113 2 (1998) 467-481